25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

532637 (Mangalam Drugs & Organics Limited) Stock Analysis
Buy, Hold or Sell?

Let's analyze Mangalam Drugs & Organics Limited together

I guess you are interested in Mangalam Drugs & Organics Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Mangalam Drugs & Organics Limited’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Mangalam Drugs & Organics Limited’s Price Targets

I'm going to help you getting a better view of Mangalam Drugs & Organics Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Mangalam Drugs & Organics Limited

I send you an email if I find something interesting about Mangalam Drugs & Organics Limited.

1. Quick Overview

1.1. Quick analysis of Mangalam Drugs & Organics Limited (30 sec.)










1.2. What can you expect buying and holding a share of Mangalam Drugs & Organics Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
INR96.00
Expected worth in 1 year
INR99.53
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
INR3.52
Return On Investment
4.0%

For what price can you sell your share?

Current Price per Share
INR88.75
Expected price per share
INR65.50 - INR101.05
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Mangalam Drugs & Organics Limited (5 min.)




Live pricePrice per Share (EOD)
INR88.75
Intrinsic Value Per Share
INR-84.52 - INR62.14
Total Value Per Share
INR11.48 - INR158.14

2.2. Growth of Mangalam Drugs & Organics Limited (5 min.)




Is Mangalam Drugs & Organics Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$17.7m$17.6m$163.1k0.9%

How much money is Mangalam Drugs & Organics Limited making?

Current yearPrevious yearGrowGrow %
Making money$148.5k$2.2m-$2.1m-1,447.8%
Net Profit Margin0.3%4.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Mangalam Drugs & Organics Limited (5 min.)




2.4. Comparing to competitors in the Drugs - Generic industry (5 min.)




  Industry Rankings (Drugs - Generic)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Mangalam Drugs & Organics Limited?

Welcome investor! Mangalam Drugs & Organics Limited's management wants to use your money to grow the business. In return you get a share of Mangalam Drugs & Organics Limited.

First you should know what it really means to hold a share of Mangalam Drugs & Organics Limited. And how you can make/lose money.

Speculation

The Price per Share of Mangalam Drugs & Organics Limited is INR88.75. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Mangalam Drugs & Organics Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Mangalam Drugs & Organics Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR96.00. Based on the TTM, the Book Value Change Per Share is INR0.88 per quarter. Based on the YOY, the Book Value Change Per Share is INR12.49 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Mangalam Drugs & Organics Limited.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.010.0%0.010.0%0.150.2%0.120.1%0.070.1%0.080.1%
Usd Book Value Change Per Share0.010.0%0.010.0%0.150.2%0.120.1%0.070.1%0.110.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.010.0%0.010.0%0.150.2%0.120.1%0.070.1%0.110.1%
Usd Price Per Share1.14-1.14-1.20-1.17-0.90-1.14-
Price to Earnings Ratio121.95-121.95-8.28-45.29-26.16-18.34-
Price-to-Total Gains Ratio111.04-111.04-8.23-41.71-24.03-16.29-
Price to Book Ratio1.02-1.02-1.08-1.10-0.94-1.81-
Price-to-Total Gains Ratio111.04-111.04-8.23-41.71-24.03-16.29-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.038375
Number of shares963
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.07
Usd Total Gains Per Share0.010.07
Gains per Quarter (963 shares)9.9368.61
Gains per Year (963 shares)39.71274.42
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1040300274264
2079700549538
301191100823812
40159150010981086
50199190013721360
60238230016471634
70278270019211908
80318310021952182
90357350024702456
100397390027442730

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%8.02.00.080.0%8.02.00.080.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%9.01.00.090.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%1.00.09.010.0%1.00.09.010.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%9.01.00.090.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Mangalam Drugs & Organics Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.8810.8810%12.494-93%10.112-91%6.089-86%9.600-91%
Book Value Per Share--96.00396.0030%95.122+1%91.251+5%79.972+20%59.166+62%
Current Ratio--1.2491.2490%1.402-11%1.293-3%1.225+2%1.228+2%
Debt To Asset Ratio--0.5770.5770%0.542+7%0.541+7%0.544+6%0.607-5%
Debt To Equity Ratio--1.3671.3670%1.181+16%1.189+15%1.199+14%1.918-29%
Dividend Per Share----0%-0%-0%-0%0.050-100%
Enterprise Value---428057737.500-428057737.5000%-131162487.500-69%-104401058.333-76%-270693711.500-37%236245598.650-281%
Eps--0.8020.8020%12.419-94%10.298-92%6.207-87%6.976-88%
Ev To Sales Ratio---0.115-0.1150%-0.029-75%-0.026-77%-0.094-18%0.024-581%
Free Cash Flow Per Share--7.3357.3350%-1.238+117%1.214+504%5.273+39%5.031+46%
Free Cash Flow To Equity Per Share---3.164-3.1640%0.644-591%-1.090-66%-0.521-84%-0.260-92%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--62.136----------
Intrinsic Value_10Y_min---84.519----------
Intrinsic Value_1Y_max--5.491----------
Intrinsic Value_1Y_min---1.240----------
Intrinsic Value_3Y_max--17.059----------
Intrinsic Value_3Y_min---10.010----------
Intrinsic Value_5Y_max--29.302----------
Intrinsic Value_5Y_min---25.599----------
Market Cap1404752750.000-10%1548794262.5001548794262.5000%1627935512.500-5%1583352608.333-2%1220674088.500+27%1546291698.650+0%
Net Profit Margin--0.0030.0030%0.044-92%0.040-92%0.023-85%0.032-89%
Operating Margin----0%-0%-0%0.022-100%0.065-100%
Operating Ratio--0.7540.7540%0.741+2%0.719+5%1.088-31%1.330-43%
Pb Ratio0.924-10%1.0191.0190%1.081-6%1.101-7%0.936+9%1.809-44%
Pe Ratio110.611-10%121.952121.9520%8.281+1373%45.286+169%26.162+366%18.338+565%
Price Per Share88.750-10%97.85097.8500%102.850-5%100.033-2%77.120+27%97.692+0%
Price To Free Cash Flow Ratio12.100-10%13.34113.3410%-83.062+723%-36.735+375%-20.221+252%4.165+220%
Price To Total Gains Ratio100.714-10%111.041111.0410%8.232+1249%41.711+166%24.033+362%16.287+582%
Quick Ratio--0.3860.3860%0.372+4%0.421-8%0.370+4%0.419-8%
Return On Assets--0.0040.0040%0.060-94%0.056-94%0.033-89%0.048-93%
Return On Equity--0.0080.0080%0.131-94%0.118-93%0.070-88%0.114-93%
Total Gains Per Share--0.8810.8810%12.494-93%10.112-91%6.089-86%9.650-91%
Usd Book Value--17778875.40017778875.4000%17615683.800+1%16898840.400+5%14809984.020+20%10957052.340+62%
Usd Book Value Change Per Share--0.0100.0100%0.146-93%0.118-91%0.071-86%0.112-91%
Usd Book Value Per Share--1.1231.1230%1.113+1%1.068+5%0.936+20%0.692+62%
Usd Dividend Per Share----0%-0%-0%-0%0.001-100%
Usd Enterprise Value---5008275.529-5008275.5290%-1534601.104-69%-1221492.383-76%-3167116.425-37%2764073.504-281%
Usd Eps--0.0090.0090%0.145-94%0.120-92%0.073-87%0.082-88%
Usd Free Cash Flow--1358311.5001358311.5000%-229308.300+117%224764.800+504%976533.480+39%931668.660+46%
Usd Free Cash Flow Per Share--0.0860.0860%-0.014+117%0.014+504%0.062+39%0.059+46%
Usd Free Cash Flow To Equity Per Share---0.037-0.0370%0.008-591%-0.013-66%-0.006-84%-0.003-92%
Usd Market Cap16435607.175-10%18120892.87118120892.8710%19046845.496-5%18525225.518-2%14281886.835+27%18091612.874+0%
Usd Price Per Share1.038-10%1.1451.1450%1.203-5%1.170-2%0.902+27%1.143+0%
Usd Profit--148590.000148590.0000%2299927.500-94%1907037.600-92%1149408.000-87%1291911.660-88%
Usd Revenue--43553589.30043553589.3000%52775002.800-17%46935014.100-7%40093447.680+9%34328015.280+27%
Usd Total Gains Per Share--0.0100.0100%0.146-93%0.118-91%0.071-86%0.113-91%
 EOD+4 -4MRQTTM+0 -0YOY+10 -253Y+9 -265Y+14 -2210Y+16 -22

3.3 Fundamental Score

Let's check the fundamental score of Mangalam Drugs & Organics Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15110.611
Price to Book Ratio (EOD)Between0-10.924
Net Profit Margin (MRQ)Greater than00.003
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.386
Current Ratio (MRQ)Greater than11.249
Debt to Asset Ratio (MRQ)Less than10.577
Debt to Equity Ratio (MRQ)Less than11.367
Return on Equity (MRQ)Greater than0.150.008
Return on Assets (MRQ)Greater than0.050.004
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Mangalam Drugs & Organics Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.133
Ma 20Greater thanMa 5082.728
Ma 50Greater thanMa 10080.788
Ma 100Greater thanMa 20083.016
OpenGreater thanClose93.000
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Mangalam Drugs & Organics Limited

Mangalam Drugs & Organics Limited manufactures and sells drugs, medicines, and allied products in India and internationally. It offers a range of active pharmaceutical ingredients, intermediates, and specialty chemicals, as well as impurities for use in anti-malarial, analgesic/anti-inflammatory, anti-hypertensive, and anti-retroviral applications. Mangalam Drugs & Organics Limited was incorporated in 1972 and is based in Mumbai, India.

Fundamental data was last updated by Penke on 2025-06-24 21:41:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Mangalam Drugs & Organics Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compareΒ Mangalam Drugs & Organics Limited to theΒ Drugs - Generic industry mean.
  • A Net Profit Margin of 0.3%Β means thatΒ ₹0.00 for each ₹1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 0.3%. The company is not making a profit/loss.
  • The TTM is 0.3%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ0.3%TTM0.3%0.0%
TTM0.3%YOY4.4%-4.0%
TTM0.3%5Y2.3%-1.9%
5Y2.3%10Y3.2%-0.9%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Mangalam Drugs & Organics Limited is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Mangalam Drugs & Organics Limited to theΒ Drugs - Generic industry mean.
  • 0.4% Return on Assets means thatΒ Mangalam Drugs & Organics Limited generatedΒ ₹0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 0.4%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.4%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.4%TTM0.4%0.0%
TTM0.4%YOY6.0%-5.6%
TTM0.4%5Y3.3%-3.0%
5Y3.3%10Y4.8%-1.5%
4.3.1.3. Return on Equity

Shows how efficient Mangalam Drugs & Organics Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Mangalam Drugs & Organics Limited to theΒ Drugs - Generic industry mean.
  • 0.8% Return on Equity means Mangalam Drugs & Organics Limited generated ₹0.01Β for eachΒ ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 0.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.8%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.8%TTM0.8%0.0%
TTM0.8%YOY13.1%-12.2%
TTM0.8%5Y7.0%-6.1%
5Y7.0%10Y11.4%-4.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Mangalam Drugs & Organics Limited.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Mangalam Drugs & Organics Limited is operatingΒ .

  • Measures how much profit Mangalam Drugs & Organics Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Mangalam Drugs & Organics Limited to theΒ Drugs - Generic industry mean.
  • An Operating Margin of 0.0%Β means the company generated ₹0.00 Β for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y2.2%-2.2%
5Y2.2%10Y6.5%-4.3%
4.3.2.2. Operating Ratio

Measures how efficient Mangalam Drugs & Organics Limited is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Drugs - Generic industry mean).
  • An Operation Ratio of 0.75 means that the operating costs are ₹0.75 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 0.754. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.754. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.754TTM0.7540.000
TTM0.754YOY0.741+0.013
TTM0.7545Y1.088-0.334
5Y1.08810Y1.330-0.242
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Mangalam Drugs & Organics Limited.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Mangalam Drugs & Organics Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Drugs - Generic industry mean).
  • A Current Ratio of 1.25Β means the company has ₹1.25 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 1.249. The company is just able to pay all its short-term debts.
  • The TTM is 1.249. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.249TTM1.2490.000
TTM1.249YOY1.402-0.153
TTM1.2495Y1.225+0.024
5Y1.22510Y1.228-0.003
4.4.3.2. Quick Ratio

Measures if Mangalam Drugs & Organics Limited is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Mangalam Drugs & Organics Limited to theΒ Drugs - Generic industry mean.
  • A Quick Ratio of 0.39Β means the company can pay off ₹0.39 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 0.386. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.386. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.386TTM0.3860.000
TTM0.386YOY0.372+0.014
TTM0.3865Y0.370+0.016
5Y0.37010Y0.419-0.049
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Mangalam Drugs & Organics Limited.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Mangalam Drugs & Organics LimitedΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Mangalam Drugs & Organics Limited to Drugs - Generic industry mean.
  • A Debt to Asset Ratio of 0.58Β means that Mangalam Drugs & Organics Limited assets areΒ financed with 57.7% credit (debt) and the remaining percentage (100% - 57.7%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 0.577. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.577. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.577TTM0.5770.000
TTM0.577YOY0.542+0.036
TTM0.5775Y0.544+0.033
5Y0.54410Y0.607-0.063
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Mangalam Drugs & Organics Limited is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Mangalam Drugs & Organics Limited to theΒ Drugs - Generic industry mean.
  • A Debt to Equity ratio of 136.7% means that company has ₹1.37 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Mangalam Drugs & Organics Limited:

  • The MRQ is 1.367. The company is able to pay all its debts with equity. +1
  • The TTM is 1.367. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.367TTM1.3670.000
TTM1.367YOY1.181+0.185
TTM1.3675Y1.199+0.167
5Y1.19910Y1.918-0.718
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every ₹1 in earnings Mangalam Drugs & Organics Limited generates.

  • Above 15 is considered overpriced butΒ always compareΒ Mangalam Drugs & Organics Limited to theΒ Drugs - Generic industry mean.
  • A PE ratio of 121.95 means the investor is paying ₹121.95Β for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Mangalam Drugs & Organics Limited:

  • The EOD is 110.611. Based on the earnings, the company is expensive. -2
  • The MRQ is 121.952. Based on the earnings, the company is expensive. -2
  • The TTM is 121.952. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD110.611MRQ121.952-11.342
MRQ121.952TTM121.9520.000
TTM121.952YOY8.281+113.671
TTM121.9525Y26.162+95.790
5Y26.16210Y18.338+7.824
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Mangalam Drugs & Organics Limited:

  • The EOD is 12.100. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 13.341. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 13.341. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD12.100MRQ13.341-1.241
MRQ13.341TTM13.3410.000
TTM13.341YOY-83.062+96.403
TTM13.3415Y-20.221+33.562
5Y-20.22110Y4.165-24.386
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Mangalam Drugs & Organics Limited is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Drugs - Generic industry mean).
  • A PB ratio of 1.02 means the investor is paying ₹1.02Β for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Mangalam Drugs & Organics Limited:

  • The EOD is 0.924. Based on the equity, the company is cheap. +2
  • The MRQ is 1.019. Based on the equity, the company is underpriced. +1
  • The TTM is 1.019. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.924MRQ1.019-0.095
MRQ1.019TTM1.0190.000
TTM1.019YOY1.081-0.062
TTM1.0195Y0.936+0.084
5Y0.93610Y1.809-0.874
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets3,596,288
Total Liabilities2,076,726
Total Stockholder Equity1,519,562
 As reported
Total Liabilities 2,076,726
Total Stockholder Equity+ 1,519,562
Total Assets = 3,596,288

Assets

Total Assets3,596,288
Total Current Assets2,065,841
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 4,683
Short-term Investments 72,991
Net Receivables 465,329
Inventory 1,374,665
Other Current Assets 125,518
Total Current Assets  (as reported)2,065,841
Total Current Assets  (calculated)2,043,186
+/- 22,655
Long-term Assets
Property Plant Equipment 1,335,525
Intangible Assets 182,991
Long-term Assets  (as reported)0
Long-term Assets  (calculated)1,518,516
+/- 1,518,516

Liabilities & Shareholders' Equity

Total Current Liabilities1,653,575
Long-term Liabilities0
Total Stockholder Equity1,519,562
Total Current Liabilities
Short-term Debt 495,671
Total Current Liabilities  (as reported)1,653,575
Total Current Liabilities  (calculated)495,671
+/- 1,157,904
Long-term Liabilities
Long term Debt Total 255,054
Long term Debt 187,664
Capital Lease Obligations Min Short Term Debt-495,671
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)-52,953
+/- 52,953
Total Stockholder Equity
Common Stock158,282
Retained Earnings 1,137,527
Capital Surplus 223,753
Total Stockholder Equity (as reported)1,519,562
Total Stockholder Equity (calculated)1,519,562
+/-0
Other
Cash And Equivalents22,200
Cash and Short Term Investments 99,874
Common Stock Shares Outstanding 15,828
Liabilities and Stockholders Equity 3,596,288
Net Working Capital 412,266



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
1,254,443
1,698,950
1,597,639
1,895,038
2,267,874
2,113,549
2,306,671
2,641,089
3,284,257
3,596,288
3,596,2883,284,2572,641,0892,306,6712,113,5492,267,8741,895,0381,597,6391,698,9501,254,443
   > Total Current Assets 
714,150
1,160,369
996,538
957,848
1,228,416
1,050,397
1,191,747
1,339,209
1,824,656
2,065,841
2,065,8411,824,6561,339,2091,191,7471,050,3971,228,416957,848996,5381,160,369714,150
       Cash And Cash Equivalents 
1,023
6,794
4,953
6,273
4,303
14,334
16,291
837
14,349
4,683
4,68314,34983716,29114,3344,3036,2734,9536,7941,023
       Short-term Investments 
1,792
2,402
2,401
2,439
16,561
0
0
0
0
72,991
72,991000016,5612,4392,4012,4021,792
       Net Receivables 
297,162
442,738
301,443
368,167
452,077
176,307
399,829
543,122
464,901
465,329
465,329464,901543,122399,829176,307452,077368,167301,443442,738297,162
       Inventory 
364,776
573,404
473,406
372,495
601,342
734,532
648,427
585,875
1,171,055
1,374,665
1,374,6651,171,055585,875648,427734,532601,342372,495473,406573,404364,776
       Other Current Assets 
47,727
132,032
211,022
185,368
170,569
125,136
127,104
204,203
168,794
125,518
125,518168,794204,203127,104125,136170,569185,368211,022132,03247,727
   > Long-term Assets 
0
0
0
937,189
1,037,058
1,040,864
1,114,923
0
0
0
0001,114,9231,040,8641,037,058937,189000
       Property Plant Equipment 
533,843
529,479
591,170
925,090
1,012,273
1,032,061
961,736
1,142,137
1,267,947
1,335,525
1,335,5251,267,9471,142,137961,7361,032,0611,012,273925,090591,170529,479533,843
       Intangible Assets 
0
0
0
472
7,531
4,852
61,359
99,566
138,763
182,991
182,991138,76399,56661,3594,8527,531472000
> Total Liabilities 
1,022,214
1,405,309
982,396
1,037,867
1,230,209
1,156,919
1,267,284
1,333,229
1,778,643
2,076,726
2,076,7261,778,6431,333,2291,267,2841,156,9191,230,2091,037,867982,3961,405,3091,022,214
   > Total Current Liabilities 
614,337
994,319
728,692
777,596
998,447
908,147
1,094,670
1,090,777
1,301,133
1,653,575
1,653,5751,301,1331,090,7771,094,670908,147998,447777,596728,692994,319614,337
       Short-term Debt 
771,801
779,227
353,757
413,200
507,519
505,120
418,608
511,816
470,962
495,671
495,671470,962511,816418,608505,120507,519413,200353,757779,227771,801
       Short Long Term Debt 
771,801
779,227
598,210
662,030
577,827
543,013
458,648
0
0
0
000458,648543,013577,827662,030598,210779,227771,801
       Accounts payable 
208,673
547,729
206,750
207,755
376,251
324,135
565,934
0
0
0
000565,934324,135376,251207,755206,750547,729208,673
       Other Current Liabilities 
0
0
638
1,694
10,726
2,878
18,817
0
0
0
00018,8172,87810,7261,69463800
   > Long-term Liabilities 
0
0
0
308,890
231,763
229,282
172,614
0
0
0
000172,614229,282231,763308,890000
       Long term Debt Total 
0
0
169,215
168,511
111,464
105,446
49,733
100,660
342,558
255,054
255,054342,558100,66049,733105,446111,464168,511169,21500
       Capital Lease Obligations 
0
0
0
0
0
0
19,359
0
0
0
00019,359000000
       Long-term Liabilities Other 
0
0
0
0
1
-1
5
0
0
0
0005-110000
> Total Stockholder Equity
232,229
293,641
615,243
857,171
1,037,665
956,630
1,039,387
1,307,860
1,505,614
1,519,562
1,519,5621,505,6141,307,8601,039,387956,6301,037,665857,171615,243293,641232,229
   Common Stock
131,782
131,782
143,782
158,282
158,282
158,282
158,282
158,282
158,282
158,282
158,282158,282158,282158,282158,282158,282158,282143,782131,782131,782
   Retained Earnings 
22,444
83,856
471,461
698,889
879,383
798,348
881,105
925,825
1,123,579
1,137,527
1,137,5271,123,579925,825881,105798,348879,383698,889471,46183,85622,444
   Capital Surplus 
0
0
0
0
0
0
0
223,753
223,753
223,753
223,753223,753223,7530000000
   Treasury Stock0000000000
   Other Stockholders Equity 
0
0
84,825
0
0
3,801
4,033
0
0
0
0004,0333,8010084,82500



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue3,722,529
Cost of Revenue-2,807,072
Gross Profit915,457915,457
 
Operating Income (+$)
Gross Profit915,457
Operating Expense-0
Operating Income145,328915,457
 
Operating Expense (+$)
Research Development0
Selling General Administrative649,626
Selling And Marketing Expenses0
Operating Expense0649,626
 
Net Interest Income (+$)
Interest Income86,229
Interest Expense-0
Other Finance Cost-86,229
Net Interest Income0
 
Pretax Income (+$)
Operating Income145,328
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)22,138145,328
EBIT - interestExpense = 0
12,700
12,700
Interest Expense0
Earnings Before Interest and Taxes (EBIT)022,138
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax22,138
Tax Provision-9,438
Net Income From Continuing Ops012,700
Net Income12,700
Net Income Applicable To Common Shares12,700
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net00
 

Technical Analysis of Mangalam Drugs & Organics Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Mangalam Drugs & Organics Limited. The general trend of Mangalam Drugs & Organics Limited is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Mangalam Drugs & Organics Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Mangalam Drugs & Organics Limited Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Mangalam Drugs & Organics Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 92.00 < 97.10 < 101.05.

The bearish price targets are: 86.00 > 65.50.

Know someone who trades $532637? Share this with them.πŸ‘‡

Mangalam Drugs & Organics Limited Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Mangalam Drugs & Organics Limited. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Mangalam Drugs & Organics Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Mangalam Drugs & Organics Limited. The current macd is 2.26165215.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Mangalam Drugs & Organics Limited price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Mangalam Drugs & Organics Limited. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Mangalam Drugs & Organics Limited price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Mangalam Drugs & Organics Limited Daily Moving Average Convergence/Divergence (MACD) ChartMangalam Drugs & Organics Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Mangalam Drugs & Organics Limited. The current adx is 14.10.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Mangalam Drugs & Organics Limited shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Mangalam Drugs & Organics Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Mangalam Drugs & Organics Limited. The current sar is 70.11.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Mangalam Drugs & Organics Limited Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Mangalam Drugs & Organics Limited. The current rsi is 64.13. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Mangalam Drugs & Organics Limited Daily Relative Strength Index (RSI) ChartMangalam Drugs & Organics Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Mangalam Drugs & Organics Limited. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Mangalam Drugs & Organics Limited price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Mangalam Drugs & Organics Limited Daily Stochastic Oscillator ChartMangalam Drugs & Organics Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Mangalam Drugs & Organics Limited. The current cci is 152.22.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Mangalam Drugs & Organics Limited Daily Commodity Channel Index (CCI) ChartMangalam Drugs & Organics Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Mangalam Drugs & Organics Limited. The current cmo is 31.73.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Mangalam Drugs & Organics Limited Daily Chande Momentum Oscillator (CMO) ChartMangalam Drugs & Organics Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Mangalam Drugs & Organics Limited. The current willr is -20.64846416.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Mangalam Drugs & Organics Limited is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Mangalam Drugs & Organics Limited Daily Williams %R ChartMangalam Drugs & Organics Limited Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Mangalam Drugs & Organics Limited.

Mangalam Drugs & Organics Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Mangalam Drugs & Organics Limited. The current atr is 4.6307805.

Mangalam Drugs & Organics Limited Daily Average True Range (ATR) ChartMangalam Drugs & Organics Limited Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Mangalam Drugs & Organics Limited. The current obv is 403,871.

Mangalam Drugs & Organics Limited Daily On-Balance Volume (OBV) ChartMangalam Drugs & Organics Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Mangalam Drugs & Organics Limited. The current mfi is 93.71.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Mangalam Drugs & Organics Limited Daily Money Flow Index (MFI) ChartMangalam Drugs & Organics Limited Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Mangalam Drugs & Organics Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-28BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-05MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-17MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-03MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-04-17WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-22STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-05-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-08MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-05-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-28MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-07-03MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-07-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-07-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Mangalam Drugs & Organics Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Mangalam Drugs & Organics Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5064.133
Ma 20Greater thanMa 5082.728
Ma 50Greater thanMa 10080.788
Ma 100Greater thanMa 20083.016
OpenGreater thanClose93.000
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Mangalam Drugs & Organics Limited with someone you think should read this too:
  • Are you bullish or bearish on Mangalam Drugs & Organics Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Mangalam Drugs & Organics Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Mangalam Drugs & Organics Limited

I send you an email if I find something interesting about Mangalam Drugs & Organics Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Mangalam Drugs & Organics Limited.

Receive notifications about Mangalam Drugs & Organics Limited in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.